Skip Nav Destination
Article navigation
Meeting Abstracts|
September 1984
Atracurium: Clinical Strategies for Preventing Histamine Release and Attenuating the Hemodynamic Response
R. P.F. Scott, M.D., F.F.A.R.C.S.;
R. P.F. Scott, M.D., F.F.A.R.C.S.
Search for other works by this author on:
Department of Anesthesia, Harvard Medical School, Massachusetts General Hospital, Boston, MA and Medical Department, Burroughs Wellcome Company, Research Triangle Park, NC
Anesthesiology September 1984, Vol. 61, A287.
Citation
R. P.F. Scott, J. J. Savarese, H. H. Ali, M. Gargarian, S. J. Basta, H. Sunder, M. Gionfriddo, A. Gail Baston; Atracurium: Clinical Strategies for Preventing Histamine Release and Attenuating the Hemodynamic Response. Anesthesiology 1984; 61:A287 doi: https://doi.org/10.1097/00000542-198409001-00287
Download citation file:
Citing articles via
Most Viewed
Related Articles
The Cardiovascular Effects and Histamine-releasing Properties of 51W89 in Patients Receiving Nitrous Oxide/Opioid/Barbiturate Anesthesia
Anesthesiology (May 1995)
Atracurium Versus Vecuronium in Asthmatic Patients: A Blinded, Randomized Comparison of Adverse Events
Anesthesiology (November 1995)
Different Patterns of Mast Cell Activation by Muscle Relaxants in Human Skin
Anesthesiology (September 2001)
Mechanisms of Nonimmunological Histamine and Tryptase Release from Human Cutaneous Mast Cells
Anesthesiology (April 2000)
Comparative Pharmacology of Cisatracurium (51W89), Atracurium, and Five Isomers in Cats
Anesthesiology (July 1996)